NOTICE AND PROXY

Company

BIOCRYST PHARMACEUTICALS INC

Filed

April 9, 2012

Period of Report

May 23, 2012

Accession Number

0001193125-12-154493

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →